Related Experiment Video
Updated: May 5, 2026

10:03
Generation of Recombinant Arenavirus for Vaccine Development in FDA-Approved Vero Cells
Published on: August 1, 2013
16.3K
Recent progress toward development of vaccines against conception.
1Department of Obstetrics and Gynecology, Reproductive Immunology and Molecular Biology Laboratory, School of Medicine, West Virginia University, Morgantown, WV, USA.
Expert Review of Vaccines
|December 7, 2013
Summary
Contraceptive vaccines (CVs) offer a promising solution to global population challenges and unintended pregnancies. This review explores the current status and future potential of CVs for both human and animal population control.
Area of Science:
- Reproductive Health
- Vaccinology
- Population Control
Background:
- Unintended pregnancies and population growth pose significant global health and resource challenges.
- Existing contraceptive methods have limitations, necessitating novel approaches.
- Contraceptive vaccines (CVs) are emerging as a potential ideal contraceptive solution.
Purpose of the Study:
- To review the current advancements in contraceptive vaccine (CV) development.
- To discuss the future perspectives and potential applications of CVs.
- To cover CVs for both human and animal population management.
Main Methods:
- Literature review of existing research on contraceptive vaccines.
- Analysis of the properties and potential of CVs as an ideal contraceptive.
- Exploration of applications in human and various animal populations.
Main Results:
- Contraceptive vaccines (CVs) show potential to meet the criteria for an ideal contraceptive.
- Significant research attention is being directed towards CV development.
- CVs are being considered for both human use and control of animal populations.
Conclusions:
- Contraceptive vaccines represent a significant advancement in reproductive health.
- Further development of CVs is crucial for addressing global population and resource issues.
- CVs hold promise for effective human and animal population management strategies.
Related Concept Videos
Vaccine Production
144
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
144
Development of Immunocompetence
1.2K
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
1.2K
Vaccines
98
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the...
98
Vaccinations
44.1K
Overview
44.1K
Cancer Vaccines
1.3K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.3K
Preclinical Development: Overview
4.8K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.8K

